Ind-Swift Laboratories Ltd has disclosed the acquisition of 11,00,000 equity shares from Essix Biosciences Limited effective from 4th August, 2025, following the conversion of warrants into equity.
AI Assistant
Ind-Swift Laboratories Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.